Drug Controller General of India (DCGI) News
Panacea Biotec, in a release on Sunday, announced that it has received a licence from the DCGI for manufacturing the Sputnik V vaccine in its Himachal Pradesh facility.
Sputnik V has been registered in 54 countries globally with a total population of over 1.4 billion people.
The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India (DCGI) for the treatment of COVID-19, it said in a statement.
Loading...